Sai Life Sciences Ltd. logo

Sai Life Sciences Ltd. (SAILIFE)

Market Closed
10 Aug, 10:00
XNSE XNSE
1,426. 20
+61
+4.4682%
150.37B Market Cap
- P/E Ratio
- Div Yield
2.55M Volume
- Eps
1,365.2
Previous Close
Add Transaction
Day Range
1,370 1,473.5
Year Range
783.85 1,473.5
Want to track SAILIFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SAILIFE closed today higher at ₹1,426.2, an increase of 4.4682% from yesterday's close, completing a monthly increase of 14.4623% or ₹180.2. Over the past 12 months, SAILIFE stock gained 57.2177%.
SAILIFE is not paying dividends to its shareholders.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.7433%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

SAILIFE Chart

People also search for

Cyient Ltd.
855
-0.2915%
Kirloskar Oil Engines Ltd.
2,131.2
-1.4109%
Lakshmi Machine Works Limited
17,600
+5.8392%
Blue Dart Express Ltd.
5,190.5
+1.9845%
HBL Power Systems Limited
727.1
-1.2294%

Sai Life Sciences Ltd. (SAILIFE) FAQ

What is the stock price today?

The current price is ₹1,426.20.

On which exchange is it traded?

Sai Life Sciences Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is SAILIFE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 150.37B.

Has Sai Life Sciences Ltd. ever had a stock split?

No, there has never been a stock split.

Sai Life Sciences Ltd. Profile

Professional Services Industry
Industrials Sector
Mr. Krishnam Raju Kanumuri CEO
XNSE Exchange
Y7451T124 CUSIP
India Country
2,845 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Sai Life Sciences Ltd. stands as a premier contract research and manufacturing organization (CRMO) dedicated to supporting the global pharmaceutical and biotechnology sectors. By engaging in comprehensive partnerships throughout the drug discovery, development, and manufacturing process, the company provides a spectrum of services that encompasses the entire journey from the conception of molecules to mass production. Leveraging deep expertise in chemistry, biology, and pharmaceutical sciences, Sai Life Sciences Ltd. is pivotal in expediting the development timelines of pharmaceutical entities, thereby facilitating the quicker introduction of novel treatments into the market. The organization commands a significant influence across various therapeutic domains, including but not limited to oncology, infectious diseases, and neurology. Its unwavering commitment to upholding the highest standards of quality, reliability, and adherence to international regulatory guidelines solidifies its status as a globally recognized and dependable partner. Rooted in Hyderabad, India, the company prides itself on its cutting-edge facilities and a substantial global footprint that plays a vital role in reinforcing the international pharmaceutical supply chain.

Products and Services

  • Drug Discovery Services

    Sai Life Sciences Ltd. offers comprehensive drug discovery services that span across early-stage hit identification, hit-to-lead optimization, and lead optimization. This early phase of drug development is supported by the company's extensive expertise in chemistry and biology, aimed at accelerating the identification and optimization of potential therapeutic compounds.

  • Developmental and Manufacturing Solutions

    The company provides a wide range of development and manufacturing solutions tailored to fit the needs of the pharmaceutical and biotechnology industries. This includes process development, scale-up, and commercial manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Sai Life Sciences Ltd.'s state-of-the-art facilities are equipped to handle complex chemical syntheses and are compliant with global regulatory standards, guaranteeing high-quality production outcomes.

  • Integrated End-to-End Solutions

    Understanding the importance of efficiency and cohesion in pharmaceutical development, Sai Life Sciences Ltd. offers end-to-end solutions that seamlessly integrate drug discovery, development, and manufacturing processes. This holistic approach ensures a smoother transition from molecule to market, reducing development timelines and enhancing the speed with which new therapies can be made available to patients worldwide.

Contact Information

Address: L4- 01 & 02, SLN Terminus Survey
Phone: 91 40 6815 6000